Arylsulfonamidothiazoles for the early stages of Alzheimer type dementia: A new potential for treatment

dc.authoridGULDIKEN, Baburhan/0000-0002-9006-1880
dc.contributor.authorGuldiken, Sibel
dc.contributor.authorGuldiken, Baburhan
dc.date.accessioned2024-06-12T11:17:29Z
dc.date.available2024-06-12T11:17:29Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.mehy.2010.09.017
dc.identifier.endpage145en_US
dc.identifier.issn0306-9877
dc.identifier.issn1532-2777
dc.identifier.issue1en_US
dc.identifier.pmid20889263en_US
dc.identifier.scopus2-s2.0-78650177634en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage145en_US
dc.identifier.urihttps://doi.org/10.1016/j.mehy.2010.09.017
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24720
dc.identifier.volume76en_US
dc.identifier.wosWOS:000286918400037en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherChurchill Livingstoneen_US
dc.relation.ispartofMedical Hypothesesen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject11-Beta-Hydroxysteroid Dehydrogenase Type-1en_US
dc.subjectHippocampusen_US
dc.subjectDiseaseen_US
dc.subjectPathologyen_US
dc.titleArylsulfonamidothiazoles for the early stages of Alzheimer type dementia: A new potential for treatmenten_US
dc.typeLetteren_US

Dosyalar